Format

Send to

Choose Destination
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):127-31. doi: 10.1097/QAI.0b013e31822c62b9.

Activation of NK cells by ADCC antibodies and HIV disease progression.

Author information

1
Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) is of considerable interest as an immune response that may facilitate the control of HIV infection. We studied ADCC responses prospectively in a cohort of 79 HIV-positive subjects followed up for a mean of 2.3 years without antiretroviral therapy. We used a novel assay of the ability of ADCC to activate natural killer (NK) cells, either from the same HIV-positive subject or from a healthy blood donor. We found that ADCC responses to either gp140 Env protein or HIV peptide pools were common in HIV-positive subjects when NK cells from the HIV-positive subject were used but did not correlate with markers of HIV disease progression. In contrast, ADCC responses to whole gp140 Env protein were strongly associated with a slower decline in CD4 T-cell loss when healthy donor NK cells were used as effectors. Our data had implications for induction of the most effective ADCC responses by HIV vaccines.

PMID:
21792067
PMCID:
PMC3175260
DOI:
10.1097/QAI.0b013e31822c62b9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center